Skip to main content

CAP - community-acquired pneumonie - atypische verwekker

Advices

≥ 18 years

Indications: Verwekker: Mycoplasma pneumoniae, Chlamydia psittaci of pneumoniae

Priority Medication Remarks
Medication:

doxycycline po loading dose 200mg, 100mg 1dd 14 days

or

claritromycine po 500mg 2dd 14 days

≥ 18 years

Indications: Verwekker: Legionella species

Priority Medication Remarks
Priority:
1st choice
Medication:

levofloxacine po 500mg 2dd 7 to 10 days

Priority:
2nd choice
Medication:

claritromycine po 500mg 2dd 7 to 10 days

≥ 18 years

Indications: Acute Q-koorts (Coxiella burnetti)

Priority Medication Remarks
Priority:
1st choice
Medication:

doxycycline po 200mg 1dd 14 days

Remarks:

21 dagen bij immuungecompromitteerden

Priority:
2nd choice
Medication:

moxifloxacine po 400mg 1dd 14 days

Priority:
3rd choice
Medication:

ciprofloxacine po 750mg 2dd 14 days

General comments

Legionella en Q-koorts zijn meldingsplichtige ziekten groep C

M.b.t. Q-koorts: voor de behandeling van zwangeren en van chronische infecties, waaronder endocarditis, dient men gynaecoloog, arts-microbioloog en/of internist-infectioloog te raadplegen.

Sources

  1. http://www.swab.nl/swab/cms3.nsf/uploads/6A6E127F9A2C1168C125816F004A013A/$FILE/CAP_SWAB_2017-DEF_R5.pdf

    SWAB Richtlijn CAP 2016

  2. Pubmed.gov publication # 4608426

    Gilbert J. Kersh. Antimicrobial therapies for Q fever. Expert Rev Anti Infect Ther. 2013 Nov; 11(11): 1207–1214.

Antimicrobial resources

The following antimicrobial agents have been used in these recommendations:

External antimicrobial resources
Menu position
Metadata

Swab vid: G-444301.3
Updated: 11/24/2023 - 20:19
Status: Published